Where is Benlysta manufactured?
A week after christening a new manufacturing plant in Pennsylvania, GSK has officially opened one in Maryland. The $139 million plant at its Rockville, Maryland site was built to add capacity for GSK’s lupus-fighter Benlysta, a drug that has been prescribed to 59,000 patients in the U.S. since its introduction in 2011.
Who is the manufacturer of Benlysta?
GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) has approved BENLYSTA (belimumab) for the treatment of adult patients with active lupus nephritis (LN) who are receiving standard therapy.
Is Benlysta available in Europe?
Benlysta EU Indication Benlysta SC is indicated in the EU as add-on therapy in adult patients with active, autoantibody-positive systemic lupus erythematosus with a high degree of disease activity (e.g., positive anti dsDNA and low complement) despite standard therapy.
How new is Benlysta?
Benlysta represents a breakthrough in the treatment of lupus. Benlysta is the first drug approved to treat lupus in more than 50 years AND is the first drug developed specifically for lupus since the disease was discovered more than a century ago!
Is BENLYSTA available in South Africa?
Although belimumab, known by the brand name Benlysta, was registered in 2011 in the USA, the South African Health Products Regulatory Authority (SAHPRA) has still not given approval for its use in South Africa.
Does BENLYSTA cause hair loss?
Hair loss is a rare side effect some people may experience while taking Benlysta. In clinical trials, no one reported hair loss. However, since the drug was approved, three people have reported hair loss while taking Benlysta. Specifically, the type of hair loss that was reported is called alopecia areata.
Can Benlysta cause eye problems?
Progressive multifocal leukoencephalopathy (PML). PML can result in death or severe disability. Tell your healthcare provider right away if you notice any new or worsening medical problems: memory loss, trouble thinking, dizziness or loss of balance, difficulty talking or walking, or loss of vision.
Where do you inject Benlysta?
The injection is given in the thighs or abdomen (at least 2 inches from your belly button). The dosage is based on your medical condition and response to treatment. If you are switching from receiving this medication by injection into a vein, be sure you learn how and when to start using this form of belimumab.
What is the J code for BENLYSTA?
The Centers for Medicare & Medicaid Services (CMS) has assigned a J code to BENLYSTA, which will apply to dates of service on or after January 1, 2012. The code is: J0490, INJECTION, BELIMUMAB, 10 MG.
Is there a Lupus Foundation in South Africa?
GREATING awareness and SUPPORT Lupus sufferers and Families. There is no known cause for Lupus and there is no cure. The Lupus Foundation SA was established to create awareness of the disease in the country to assist medical personnel to identify…
Is Benlysta approved by the FDA?
FDA approves GSK’s BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US | GSK 17 December 2020 FDA approves GSK’s BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US For media and investors only
What is the age range for Benlysta?
BENLYSTA is indicated for patients aged ≥5 years with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy and patients aged ≥18 with active lupus nephritis who are receiving standard therapy. The subcutaneous (SC) formulation is approved for patients aged ≥18 years.
What is indindication Benlysta used to treat?
INDICATION BENLYSTA is indicated for patients aged ≥5 years with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy and patients aged ≥18 with active lupus nephritis who are receiving standard therapy. The subcutaneous (SC) formulation is approved for patients aged ≥18 years.
What is the best way to store Benlysta?
3. The reconstituted sol ution of BENLYSTA, if not used immediately, should be stored protected from direct sunlight and refrigerated at 36°F to 46°F (2°C to 8 °C). Solutions of BENLYSTA diluted in normal saline, half -normal saline, or Lactated Ringer’s Injection may be stored at 3 6°F to 46°F (2°C to 8 °C) or room temperature.
